Loading...
•
Mar 31, 2025
Alkermes Q1 2025 Earnings Report
Reports First Quarter 2025 Financial Results
Key Takeaways
Alkermes plc reported first quarter 2025 revenues of $306.5 million and GAAP net income of $22.5 million, with diluted GAAP earnings per share of $0.13. The company reiterated its 2025 financial expectations and highlighted progress in its ALKS 2680 development program.
Total revenues for Q1 2025 were $306.5 million.
GAAP net income for Q1 2025 was $22.5 million, resulting in diluted GAAP EPS of $0.13.
Proprietary net sales increased to $244.5 million in Q1 2025 compared to $233.5 million in Q1 2024.
The company completed enrollment in the Vibrance-1 phase 2 study for ALKS 2680 and expects topline results early in Q3 2025.
Revenue by Segment
Forward Guidance
Alkermes reiterated its full-year 2025 financial expectations as previously set forth on February 12, 2025.
Positive Outlook
- Solid foundation provided by Q1 financial performance to deliver on full-year guidance.
- Strong position in the current macroeconomic environment.
- Focused on executing strategic objectives to drive future value.
- Completed enrollment in the Vibrance-1 phase 2 study for ALKS 2680.
- Strong momentum across the ALKS 2680 development program, preparing for phase 3.
Challenges Ahead
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
- No specific negative forward guidance points were provided in the report.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...